CasNo.274693-26-4,Ticagrelor EP Impurity D,2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol(274693-26-4) Suppliers

0	Negotiable

Min.Order :0
Purity: ≥95%

Keywords

2-[[(3aR,4S,6R,6aS)-6-[7-[[(1R,2S)-2-(3,4-difluorophenyl)-cyclopropyl]amino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyltetrahydro-2H,3aH-cyclopenta[d][1,3]dioxol-4-yl... Ticagrelor acetonide

Quick Details

Appearance:White to Pale Beige Sticky Solid to Solid
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store at -20°C
Transportation:

Superiority:

We provide customized and high-quality Ticagrelor EP Impurity D product for your project.

Details:

Ticagrelor EP Impurity D is an impurity of Ticagrelor, which is a reversible P2Y12 receptor antagonist used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coron